| References |
http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf, World Drug Report 2013; The challenge of new psychoactive substances, , http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf, A Report from the Global SMART Programme March 2013; (2015) Europol 2014 Annual Report on the implementation of Council Decision 2005/387/JHA, Implementation Reports, , http://www.emcdda.europa.eu/attachements.cfm/att_240380_EN_TDAN15001ENN.pdf, Publications Office of the European Union, Luxembourg; (2015) New Psychoactive Substances in Europe. An Update from the EU Early Warning System, , http://www.emcdda.europa.eu/attachements.cfm/att_235958_EN_TD0415135ENN.pdf, Publications Office of the European Union, Luxembourg; http://www.unodc.org/documents/data-and-analysis/WDR2014/World_Drug_Report_2014_web.pdf, World Drug Report 2014; Castaneto, M.S., Gorelick, D.A., Desrosiers, N.A., Hartman, R.L., Pirard, S., Huestis, M.A., Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications (2014) Drug Alcohol Depend., 144, pp. 12-41; Presley, B.C., Jansen-Varnum, S.A., Logan, B.K., Analysis of synthetic cannabinoids in botanical material: a review of analytical methods and findings (2013) Forensic Sci. Rev., 25, pp. 27-46; Shevyrin, V., Morzherin, Y., Structure, activity and classification of cannabinoids (2015) Bull. Russ. Acad. Sci. Chem., 6, pp. 1249-1266. , (in Russian); Uchiyama, N., Kikura-Hanajiri, R., Ogata, J., Goda, Y., Chemical analysis of synthetic cannabinoids as designer drugs in herbal products (2010) Forensic Sci. Int., 198, pp. 31-38; Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y., Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products (2011) Forensic Toxicol., 29, pp. 25-37; Shanks, K.G., Dahn, T., Behonick, G., Terrell, A., Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry (2012) J. Anal. Toxicol., 36, pp. 360-371; Banister, S.D., Stuart, J., Conroy, T., Longworth, M., Manohar, M., Beinat, C., Wilkinson, S.M., Kassiou, M., Structure-activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues (2015) Forensic Toxicol., 33, pp. 355-366; Banister, S.D., Wilkinson, S.M., Longworth, M., Stuart, J., Apetz, N., English, K., Brooker, L., Kassiou, M., The Synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse (2013) ACS Chem. Neurosci., 4, pp. 1081-1092; Shevyrin, V., Melkozerov, V., Nevero, A., Eltsov, O., Morzherin, Y., Shafran, Y., Identification and analytical properties of new synthetic cannabimimetics bearing 2,2,3,3-tetramethylcyclopropanecarbonyl moiety (2013) Forensic Sci. Int., 226, pp. 62-73; Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y., Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products (2012) Forensic Toxicol., 30, pp. 114-125; Shevyrin, V., Melkozerov, V., Nevero, A., Eltsov, O., Shafran, Y., Analytical characterization of some synthetic cannabinoids, derivatives of indole-3-carboxylic acid (2013) Forensic Sci. Int., 232, pp. 1-10; Uchiyama, N., Matsuda, S., Kawamura, M., Kikura-Hanajiri, R., Goda, Y., Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products (2013) Forensic Toxicol., 31, pp. 223-240; Shevyrin, V., Melkozerov, V., Nevero, A., Eltsov, O., Baranovsky, A., Shafran, Y., Synthetic cannabinoids as designer drugs: new representatives of indol-3-carboxylates series and indazole-3-carboxylates as novel group of cannabinoids. Identification and analytical data (2014) Forensic Sci. Int., 244, pp. 263-275; Shevyrin, V., Melkozerov, V., Nevero, A., Eltsov, O., Morzherin, Y., Shafran, Y., 3-Naphthoylindazoles and 2-naphthoylbenzoimidazoles as novel chemical groups of synthetic cannabinoids: chemical structure elucidation, analytical characteristics and identification of the first representatives in smoke mixtures (2014) Forensic Sci. Int., 242, pp. 72-80; Uchiyama, N., Shimokawa, Y., Kawamura, M., Kikura-Hanajiri, R., Hakamatsuka, T., Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products (2014) Forensic Toxicol., 32, pp. 266-281; Uchiyama, N., Matsuda, S., Wakana, D., Kikura-Hanajiri, R., Goda, Y., New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA), identified as designer drugs (2013) Forensic Toxicol., 31, pp. 93-100; Shevyrin, V., Melkozerov, V., Nevero, A., Eltsov, O., Shafran, Y., Morzherin, Y., Lebedev, A., Synthetic cannabinoids of indazole-3-carboxamide group bearing N-1-methoxycarbonylalkyl moiety as designer drugs (2015) Anal. Bioanal. Chem., 407, pp. 6301-6315; Uchiyama, N., Asakawa, K., Kikura-Hanajiri, R., Tsutsumi, T., Hakamatsuka, T., A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA [N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide] identified in illegal products (2015) Forensic Toxicol., 33, pp. 367-373; Westphal, F., Sönnichsen, F.D., Knecht, S., Auwärter, V., Huppertz, L., Two thiazolylindoles and a benzimidazole: novel compounds on the designer drug market with potential cannabinoid receptor activity (2015) Forensic Sci. Int., 249, pp. 133-147; Moloney, G.P., Angus, J.A., Robertson, A.D., Stoermer, M.J., Robinson, M., Wright, C.E., McRae, K., Christopoulos, A., Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: novel agonists for the CB1 receptor (2008) Eur. J. Med. Chem., 43, pp. 513-539; Moloney, G.P., Robertson, A.D., (2004) 3-Oxadiazol-5-yl-1-aminoalkyl-1H-indole derivatives; Stoliarov, B.V., Savinov, I.M., Vitenberg, A.G., Kartsova, L.A., Zenkevich, I.G., Kalmanovsky, V.I., Kalambet, Y.A., (2002) Practical Gas and Liquid Chromatography, pp. 249-252. , St. Petersburg University, St. Petersburg, (in Russian) |